Harvard Bioscience, Inc. (HBIO)
NASDAQ: HBIO · Real-Time Price · USD
0.3521
+0.0371 (11.78%)
At close: May 12, 2025, 4:00 PM
0.3701
+0.0180 (5.11%)
After-hours: May 12, 2025, 7:57 PM EDT

Harvard Bioscience Market Cap

Harvard Bioscience has a market cap or net worth of $15.57 million as of May 12, 2025. Its market cap has decreased by -90.28% in one year.

Market Cap
15.57M
Enterprise Value
45.98M
1-Year Change
-90.28%
Ranking
Category
Stock Price
$0.35

Market Cap Chart

Since March 19, 2001, Harvard Bioscience's market cap has decreased from $173.50M to $15.57M, a decrease of -91.03%. That is a compound annual growth rate of -9.50%.

History

DateMarket Cap% Change
May 9, 202513.90M-84.89%
Dec 31, 202492.00M-59.72%
Dec 29, 2023228.40M97.92%
Dec 30, 2022115.40M-59.89%
Dec 31, 2021287.70M72.07%
Dec 31, 2020167.20M44.01%
Dec 31, 2019116.10M-2.11%
Dec 31, 2018118.60M3.04%
Dec 29, 2017115.10M9.83%
Dec 30, 2016104.80M-11.04%
Dec 31, 2015117.80M-35.91%
Dec 31, 2014183.80M26.15%
Dec 31, 2013145.70M15.45%
Dec 31, 2012126.20M14.42%
Dec 30, 2011110.30M-4.42%
Dec 31, 2010115.40M9.70%
Dec 31, 2009105.20M29.08%
Dec 31, 200881.50M-42.24%
Dec 31, 2007141.10M-9.96%
Dec 29, 2006156.70M15.56%
Dec 30, 2005135.60M-3.49%
Dec 31, 2004140.50M-47.56%
Dec 31, 2003267.90M170.88%
Dec 31, 200298.90M-62.67%
Dec 31, 2001264.90M52.68%
View and export this data all the way back to 2001. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 659.45B
Johnson & Johnson 371.06B
UnitedHealth Group 345.29B
AbbVie 326.08B
Novo Nordisk 297.79B
Abbott Laboratories 231.82B
Novartis AG 214.71B
AstraZeneca 211.14B
Market Cap Rankings